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Abstract
Background: There is an urgent need for psychosocial interventions that effectively support dementia caregivers in
daily life. The Experience Sampling Methodology (ESM) offers the possibility to provide a more dynamic view
of caregiver functioning. ESM-derived feedback may help to redirect caregivers’ behavior towards situations
that elicit positive emotions and to increase their feelings of competence in the caretaking process. This
paper presents the design of a study that evaluates the process characteristics and effects of the ESM-based
intervention ‘Partner in Sight’.
Methods/design: A randomized controlled trial with 90 spousal caregivers of people with dementia will be
conducted. Participants will be randomly assigned to the experimental (6-week ESM intervention including
feedback), pseudo-experimental (6-week ESM intervention without feedback), or control group (care as usual).
Assessments will be performed pre- and post-intervention and at 2-, and 6-month follow-up. Main outcomes
will be sense of competence, perceived control, momentary positive affect, and psychological complaints
(depressive symptoms, perceived stress, anxiety, momentary negative affect). In addition to the effect evaluation, a
process and economic evaluation will be conducted to investigate the credibility and generalizability of the
intervention, and its cost-effectiveness.
Discussion: The potential effects of the ESM intervention may help caregivers to endure their care responsibilities and
prevent them from becoming overburdened. This is the first ESM intervention for caregivers of people with dementia.
The results of this study, therefore, provide a valuable contribution to the growing knowledge on m-health
interventions for dementia caregivers.
Trial registration: Dutch Trial Register NTR4847; date registered Oct 9, 2014.
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Background
Caregivers of people with dementia (PwD) are at great
risk of becoming overburdened and of developing psy-
chological and physical symptoms during the caretaking
process [1]. This calls for psychosocial interventions that
effectively support caregivers of PwD in daily life and
help them handling their care responsibilities.
Various psycho-social interventions have been devel-
oped in recent years for caregivers of PwD, including
psycho-education, emotional support, practical assistance,
cognitive-behavioral therapy, and multi-component inter-
ventions [2]. Overall, research has shown significant but
small effects of current interventions on caregiver out-
comes. A common feature in these studies is that outcome
measures include retrospective self-assessments that are
highly susceptible to emotional and cognitive biases [3].
Moreover, retrospective methods do not provide informa-
tion about fluctuations in subjective experiences over time
and across situations that caregivers of PwD may face due
to the continually changing care demands.
The Experience Sampling Methodology (ESM) is an in-
novative approach in assessing subjective experiences in
real-time within the flow of daily life. ESM consists of a
structured diary method in which repeated self-assessments
are electronically recorded the moment they occur, in their
natural setting [4, 5]. ESM offers the possibility to provide a
more accurate and detailed view of caregiver functioning,
since it enables daily fluctuations in subjective experiences
to be explored and it minimizes retrospective recall biases
[6, 7]. Therefore, ESM might be a valuable addition to
standard retrospective methods, particularly in older popu-
lations with an increased incidence of memory deficits [8].
Recently, there has been growing interest in adapting
ESM to clinical practice. By using modern technology,
such as personal digital assistants (PDAs) and apps, mo-
mentary data are immediately available to both care-
givers and professionals. This creates the opportunity to
develop ESM interventions that provide explicit, visual-
ized feedback on implicit dynamic patterns of feelings,
experiences, and behavior [9, 10]. Receiving feedback on
behavior can result in emotional and behavioral change,
something already known from the field of behavioral
therapy [11, 12]. The feedback may help caregivers redir-
ect their behavior towards situations that are conducive
to positive emotional experiences. In this way, ESM of-
fers the opportunity to actively involve caregivers in
their own empowering process and to provide more per-
sonally tailored support [13]. Both these aspects have
been demonstrated to be essential in effective psycho-
social interventions [14, 15].
A focus on positive experiences facilitates a more positive
interaction between the caregiver and the PwD and in-
creases positive emotions in both the parties [16]. According
to the ‘broaden-and-build theory’, positive emotions elevate
the ability to cope with stressful situations and might conse-
quently help to increase caregivers’ feelings of being capable
of caring for the PwD [17, 18]. Positive emotions could thus
be an important target in caregiver support interventions,
increasing caregiver well-being and reducing long-term
negative impacts, such as stress and burden [19, 20].
In a recent study, ESM-derived feedback on positive
affect was provided to persons with depression during a 6-
week intervention period. Its results showed that personal-
ized feedback increased self-awareness and resulted in a sig-
nificant decline in depressive symptoms [9]. In another
ESM study, in which depressed individuals collected ESM
data for scientific purposes but without receiving feedback,
some participants reported that responding to the ESM
questionnaires had already ‘helped them’ and enhanced
their awareness of their daily functioning [21]. So far, few
studies have applied ESM in caregivers of PwD in the con-
text of research [22, 23]. Recent evidence suggests that
ESM is a feasible method for use with this often elderly and
vulnerable population (van Knippenberg et al.: Dealing with
daily challenges in dementia (Deal-id study): an innovative
approach to assess caregiver functioning in the flow of daily
life, submitted). However, to date, no ESM interventions
have been developed to support caregivers of PwD in deal-
ing with daily challenges associated with dementia. This
paper describes the design of a randomized controlled trial
(RCT) to evaluate the effects of the ESM-based intervention
program ‘Partner in Sight’ for spousal caregivers of PwD.
Study aims
The specific objectives of the current study are:
1. Process evaluation to investigate the internal and
external validity of the intervention based on
sampling quality (recruitment, randomization,
and reach) and intervention quality (relevance,
feasibility, and performance according to protocol).
The process evaluation will be conducted prior
to the effect evaluation in order to provide
essential information about credibility and
generalizability [24].
2. Effect evaluation to assess whether ‘Partner in Sight’
is superior to a pseudo-intervention and control group
in terms of producing a clinically significant increase
in subjective well-being, as proven by an increase in
caregivers’ sense of competence, perceived control,
momentary positive affect, and a decrease in psycho-
logical complaints (depression, anxiety, stress, and
momentary negative affect). A follow-up evaluation
will be conducted to examine whether the effects have
lasted two and six months after the intervention.
3. Economic evaluation to assess the cost-effectiveness of
‘Partner in Sight’ by estimating the impact of the
intervention on resource use, costs, and health outcomes.
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Methods and design
The study is a randomized controlled trial with three treat-
ment arms. The experimental condition in which caregivers
participate in the ESM-intervention ‘Partner in Sight’ (ESM
data collection including feedback) will be compared with a
pseudo-experimental condition (ESM data collection with-
out feedback) and a control group (care as usual). Data will
be collected pre- and post-intervention and at two- and
six-months follow-up (Fig. 1).
Study population
The study population will consist of spousal caregivers of
community dwelling people with all subtypes and stages of
dementia. No age limit will be applied. Participants will be
recruited in memory clinics (Maastricht University Medical
Center + (MUMC+), Atrium Medical Center Parkstad),
ambulatory mental health care institutions (Virenze-
RIAGG Maastricht, Lionarons GGZ), dementia day care
centers (Sevagram, NOVIzorg, Orbis Glana, Proteion, care
farm Ransdalerveld), and caregiver support services (Hulp
bij Dementie, Steunpunt Mantelzorg) in the southern re-
gion of the Netherlands, and via the website of the Dutch
Alzheimer Society. The clinician or care counselor who is
involved in the treatment of the PwD will approach care-
givers to participate in the study. Subsequently, potential
participants will be contacted and screened by the re-
searcher to make sure that they fully meet the following in-
clusion criteria: (1) being a spousal caregiver of a person
with a diagnosis of dementia; (2) sharing a household with
the PwD; and (3) informed consent obtained. Exclusion cri-
teria will be: insufficient cognitive abilities to engage in
ESM; being overburdened or having severe health problems
based on clinical judgment of a knowledgeable practitioner;
taking care for a PwD caused by Human Immunodeficiency
Virus (HIV), acquired brain injury, Down syndrome, chorea
related to Huntington’s disease or alcohol abuse.
Randomization
Caregivers will be randomly assigned to the experimental
group, pseudo-experimental group, or control group.
Randomization will be computer-generated and conducted
by an independent statistician. Block randomization will be
performed to diminish the risk of an unbalanced assign-
ment to the three treatment arms. Randomly permuted
blocks with variable block sizes (3, 6, and 9) will be used,
by which the block size and specific order will be chosen
randomly at the beginning of each block. This reduces the
risk of predicting group assignment and keeps research
staff blind to the randomization process. The design of
this study is single-blind. An independent research assist-
ant, who is being blinded to the treatment allocation, will
conduct the baseline, post-intervention and follow-up
assessments, and will be asked to evaluate success of
blinding and reasons for possible unmasking on the Case
Record Form.
ESM procedure
ESM will be carried out using the PsyMate, an electronic
touchscreen device that is specifically designed to monitor
experiences and behavior in daily life and that offers the
possibility to provide immediate ESM-derived feedback
(www.psymate.eu). The PsyMate has been extensively
studied and refined in several studies concerning psychi-
atric populations (e.g. psychosis and depression) [10, 13].
In a recent ESM study with spousal caregivers of PwD, the
PsyMate was considered to be a user-friendly and easily
accessible device (van Knippenberg et al.: Dealing with
daily challenges in dementia (Deal-id study): an innovative
approach to assess caregiver functioning in the flow of
daily life, submitted).
The PsyMate will be programmed to generate ten beeps
(sound and vibration) per day at random intervals
between 7:30 AM and 10:30 PM. ESM will be used as an
assessment tool during the baseline assessment (three
consecutive days = 30 beeps in total) and the post assess-
ment (three consecutive days = 30 beeps in total) to
evaluate the effectiveness of the intervention. Further-
more, ESM will be used as an intervention tool during the
6-week intervention period (three consecutive days per
week = 10×3×6 = 180 beeps in total). In order to include
different days of the week, the PsyMate will beep alter-
nately on Friday, Saturday, and Sunday, or Tuesday,
Wednesday, and Thursday during the intervention period.
After each beep, caregivers will be asked to complete a
questionnaire presented on the screen of the PsyMate,
including current affect (four positive affect and eight
negative affect items), self-esteem (four items), physical
well-being (four items), as well as current context and
activities (daily life activities, social company, location
and events). At the end of each questionnaire, caregivers
will have to indicate whether the beep disturbed them.
Fig. 1 CONSORT flow diagram
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Answering all questions will take approximately three
minutes per beep (van Knippenberg et al.: Dealing with
daily challenges in dementia (Deal-id study): an innova-
tive approach to assess caregiver functioning in the flow
of daily life, submitted). Additionally, the PsyMate will
be programmed to generate a morning and evening
questionnaire at the beginning and end of each day. The
morning questionnaire consists of six items regarding
their sleep quality during the previous night and their
current level of energy. The evening questionnaire con-
tains twenty-five items concerning the caregivers’ daily
sense of well-being and competence, and neuropsychi-
atric symptoms in the PwD during that day. Responses
will be rated on 7-point Likert scales (ranging from 1
‘not at all’ to 7 ‘very much’), bipolar scales (ranging
from −3 ‘very unpleasant/very unimportant’ to +3
‘very pleasant/very important’), a Visual Analogue
Scale (ranging from 0 ‘worst imaginable health’ to 100
‘best imaginable health’), and box-checking formats.
Responses cannot be corrected afterwards. An over-
view of the ESM items with corresponding response
choices and concepts is presented in the Appendix.
The specific items of the ESM questionnaires were
developed and selected according to information
available from previous ESM studies [25, 26], knowledge
about the experiences and situations that caregivers of
PwD could be expected to encounter in daily life, and the
guidelines for item development created by ESM experts
[27]. Moreover, the ESM questionnaires were recently
tested in a feasibility study that yielded positive results
(van Knippenberg et al.: Dealing with daily challenges in
dementia (Deal-id study): an innovative approach to assess
caregiver functioning in the flow of daily life, submitted).
Study procedure
Baseline assessment (T0)
After the randomization procedure, a baseline assess-
ment (T0) will take place in the caregiver’s home or at
the MUMC+ according to their preference. Participants
will be asked by the research assistant to sign the in-
formed consent before continuation of the study proced-
ure. Next, a demographical interview will be conducted
to assess caregiver and care recipient characteristics.
Additionally, caregivers will be asked to participate in a
3-day ESM baseline measurement, starting the day after
the baseline assessment. A 30-min briefing will be pro-
vided during the baseline assessment to ensure that they
fully understand the procedure and how to operate the
PsyMate. A demo questionnaire will be presented to
familiarize caregivers with the device and a leaflet contain-
ing all relevant information regarding the use of the device
will be handed out. Finally, the caregivers will be asked to
complete a number of retrospective questionnaires at their
own convenience as part of the effect evaluation.
Intervention period
Experimental group Caregivers in the experimental
group will participate in the 6-week intervention ‘Partner in
Sight’ and collect ESM data for three consecutive days a
week. Every two weeks they will receive ESM-derived feed-
back in a face-to-face session with a coach in their home or
at the MUMC+ according to their preference. This sums
up to a total of three feedback sessions. The aim of the feed-
back sessions is to provide an overview of the caregiver’s
everyday functioning, including their mood (i.e. levels of
positive affect), daily life activities, and social interactions.
The focus will be on positive rather than negative emotional
experiences and how these relate to specific daily contexts.
In this way, we try stimulate caregivers to redirect their be-
havior towards situations that elicit positive emotions.
At the beginning of each feedback session average
levels of positive affect experienced during the past two
weeks will be presented. Subsequently, a feedback mod-
ule on daily activities and/or social interactions in daily
life will be discussed with the caregiver. Feedback mod-
ules are based on an existing ESM intervention, which
has proven to be effective in people with depression [9].
During the first feedback session the module ‘daily
activities’ will be discussed with the caregiver. The data
may, for example, illustrate that positive emotions increase
during moments of active relaxation, while the caregiver is
actually spending the least amount of time on active relax-
ation activities. The coach will stimulate caregivers to
think about the findings and to implement new insights
into their daily lives. In the second feedback session the
module ‘social interactions in daily life’ will be added. A
caregiver might state, for example, that he prefers to
spend his time alone, without any company. The feedback,
however, may show that positive emotions are experienced
particularly while being in company instead of when being
alone. This finding might induce an increase in social in-
teractions, which in turn may lead to increased positive
emotions. The third session will combine both modules.
At the end of each session the weekly progress in levels of
positive affect yielded by daily activities and/or social in-
teractions will be evaluated. A more detailed description
of the feedback modules is presented in Table 1.
The coach will present all feedback verbally and graphic-
ally (in clear pie charts and bar graphs) to the caregiver ac-
cording to a standardized protocol. Before the start of the
study all coaches will receive training with clear instructions
on how to provide feedback. After each session both the
caregiver as well as the involved clinician or care counselor
will be provided with a written copy of the feedback.
At the end of each feedback session there will be a
debriefing concerning the use of the PsyMate, e.g. difficul-
ties operating the device, technical problems, items that
are unclear, and reasons for missing measurements. Fur-
thermore, the participant will be reminded and encouraged
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to fill out the PsyMate during the following two weeks as
accurately as possible conform the instructions given by
the coach. During the third feedback session the coach will
additionally conduct an unstructured interview to assess
the feasibility of the intervention.
Pseudo-experimental group A pseudo-experimental
group is added to the study design to investigate whether
the ESM-derived feedback adds value to the use of the
PsyMate without receiving any direct feedback. Repeated
self-assessments might already increase caregivers’ self-
awareness and redirect their behavior accordingly [21].
Caregivers in the pseudo-experimental group will
participate in a 6-week pseudo-intervention and col-
lect ESM data for three days a week. Every two weeks
they will receive a face-to-face session with a coach.
However, during these sessions they will not be provided
with feedback on their daily recordings. Alternatively, a
semi-structured interview on their well-being during
the past two weeks will be performed to prevent any
effects of different duration of contact with the coach.
At the end of each session caregivers will, similar to
the participants in the experimental group, be provided
with a debriefing concerning the use of the ESM-device.
Control group Caregivers in the control group will
receive care as usual during the 6-week intervention
period. Care conditions will differ among caregivers and
will be registered carefully at baseline. In general, care as
usual includes low-frequent sessions with a clinician
from the memory clinic or counselor from a caregiver
support service.
Post-intervention assessment (T1)
After the intervention period a post-intervention as-
sessment will be executed in the caregiver’s home or
at the MUMC+ according to their preference. As
part of the post-intervention assessment, caregivers
will be asked to participate in a 3-day ESM post
measurement. They will be shortly briefed with re-
spect to the procedure. Afterwards, all participants
will be asked to complete a questionnaire concerning
their general experiences with the ESM-device dur-
ing the complete study period. Based on their an-
swers a semi-structured interview will be conducted
to discuss the questionnaire. Finally, caregivers will
be asked again to complete a number of retrospect-
ive questionnaires at their own convenience as part
of the effect evaluation.
Table 1 Feedback modules of the intervention ‘Partner in Sight’
Session Feedback Module Description
1 1 Daily activities - Pie chart of the average time spent on different activities (e.g. caring for partner,
household, active relaxation, passive relaxation, resting, self care) during the past
two weeks
- Graph demonstrating the relationship between different kind of activities and
experienced levels of positive affect
- Pie chart of the average time spent on active relaxation in the presence and
absence of the PwD
- Graph showing experienced levels of positive affect during active relaxation
in the presence and absence of the PwD
- Pie chart of the average time spent on passive relaxation in the presence and
absence of the PwD
- Graph showing experienced levels of positive affect during passive relaxation
in the presence and absence of the PwD
2 1 & 2 Social interactions Added:
- Pie chart of the average time spent in different kinds of company (e.g. partner,
friends, family, colleagues, alone) during the past two weeks
- Graph demonstrating the relationship between different types of social company
and experienced levels of positive affect
3 1 & 2 See description above
1,2,3 General graphs - Graph including information on average levels of positive affect during the past
two weeks
- Graph demonstrating the weekly progress in levels of positive affect during
the course of the intervention
- Graph demonstrating the weekly progress in levels of positive affect yielded by
daily activities
- Graph demonstrating the weekly progress in levels of positive affect yielded
by social interactions
PwD person with dementia
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Follow-up assessments (T2 & T3)
A two- and six-month follow-up assessment will be
administered in which participants receive a number
of retrospective questionnaires by post and are asked
to return them after completion.
Retention
Participants will be provided with periodic newsletters to
inform them about the current status of the study, plans for
the next phase, as well as to acknowledge their support.
Instruments
For an overview of the instruments used during the
baseline, post-intervention and follow-up assessments
see Table 2.
Primary outcome measures
Sense of Competence: caregivers’ subjective feelings of
competence will be assessed with the Short Sense of Com-
petence Questionnaire (SSCQ), a shortened version of the
27-item Sense of Competence Questionnaire (SSQ) [28].
The SSCQ consists of seven items, rated on a 5-point scale
from 1 (agree very strongly) to 5 (disagree very strongly).
The items reflect three domains of caregivers’ feelings of
being capable to care for the PwD: satisfaction with their
own performance as a caregiver (2 items), satisfaction with
the PwD as a care recipient (3 items), and consequences
of involvement in care for personal life of the caregiver (2
items). A total sum score (range 7–35) will be calculated
for each participant. Higher sum scores represent higher
levels of sense of competence. The scale displays good
content and construct validity in previous research [28].
Table 2 Flowchart of measures used during the assessments
Pre-test Intervention period Post-tests
T = 0 FB1 FB2 FB3 T = 1 T = 2 T = 3
Primary outcome measures RCT
- Sense of competence: SSCQ X X X X
- Perceived control: PMS X X X X
Secondary outcome measures RCT
- Depressive symptoms: CES-D X X X X
- Perceived stress: PSS X X X X
- Anxiety symptoms: HADS-A X X X X
ESM outcome measures RCT
- Momentary positive affect X X
- Momentary negative affect X X
Additional measures RCT
- Demographic variables X
- Neuropsychiatric symptoms in PwD: NPI-Q X X X X
- Quality of the relationship: 4 items of the University of Southern California
Longitudinal Study of Three-Generation Families measures of positive affect
X X X X
- Coping: UCL X X X X
- Personality: subscale neuroticism of NEO-FFI X X X X
Outcome measures process evaluation
- Subjective experiences with intervention:
quantitative questionnaire & qualitative semi-structured interview
X
- Subjective experiences with the use of the ESM device:
quantitative questionnaire
X
- Subjective experiences with ESM procedure:
quantitative questionnaire
X X X X
Outcome measures economic evaluation
- Resource use: RUD-lite X X X X
- Quality of life: EQ-5D X X X X
RCT randomized controlled trial, SSCQ Short Sense of Competence Questionnaire, PMS Pearlin Mastery Scale, CES-D Center for Epidemiological Studies Depression
Scale, PSS Perceived Stress Scale, HADS-A Hospital Anxiety and Depression Scale, Anxiety subscale, PwD person with dementia, NPI-Q Neuropsychiatric Inventory
Questionnaire, UCL Utrechtse Coping List, NEO-FFI NEO Five-Factor Inventory, ESM Experience Sampling Methodology, RUD-lite Resource Utilization in Dementia –
shortened version, EQ-5D EuroQoL-5D
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Perceived control: the extent to which a person per-
ceives him- or herself to be in control of events and
on-going situations, also known as mastery, will be
measured with the Pearlin Mastery Scale (PMS) [29].
The scale contains seven items with scores varying
from 0 (completely agree) to 4 (completely disagree).
Items are summed to form a total mastery score
(range 0–28), with higher scores indicating greater
perceived control. The psychometric properties of the
PMS are good according to previous research [30].
Secondary outcome measures
Depressive symptoms: the Center for Epidemiological
Studies Depression Scale (CES-D) will be used to assess
depressive symptoms among caregivers [31]. It includes
twenty items that rate the frequency of symptoms during
the past week. Item scores range from 0 (rarely or none
of the time present [less than 1 day]) to 3 (most or all of
the time present [5–7 days]). The total sum score ranges
from 0 to 60, with higher scores indicating more depres-
sive symptoms. Items depict major components of de-
pressive symptomatology, such as depressed mood,
feelings of guilt and worthlessness, feelings of helpless-
ness and hopelessness, psychomotor retardation, loss of
appetite, and sleep disturbance. The CES-D has been
widely used in research on caregiving and has proven to
be sensitive to changes in caregiver depressive symptoms
after intervention [14].
Perceived stress: the Perceived Stress Scale (PSS) will
be used to measure the degree to which situations in
one’s life are appraised as stressful [32]. The PSS consists
of ten items, rated on a 5-point scale from 0 (never) to 4
(very often), regarding unpredictability, control, and
overload. Total sum scores on the PSS range from 0 to
40, with higher scores representing higher levels of
stress. Adequate validity and reliability has been demon-
strated in previous research [32].
Anxiety symptoms: the 7-item anxiety subscale of the
Hospital Anxiety and Depression Scale (HADS) will be
employed to assess the severity of anxiety symptoms in
caregivers [33]. Item scores range from 0 (not at all) to 3
(a great deal of the time) and will be accumulated to
produce a total sum score (range 0–21), with higher
scores indicating more anxiety. The HADS has fre-
quently been used in caregivers of PwD and has shown
good reliability rates [34].
ESM outcome measures
Momentary positive and negative affect: the ESM data
collected during the 3-day ESM baseline measurement
and 3-day ESM post measurement will be used to assess
caregivers’ momentary positive and negative affect. Posi-
tive affect will be defined as the mean score of the items:
‘I feel cheerful’, ‘I feel relaxed’, ‘I feel enthusiastic’, and ‘I
feel satisfied’. Negative affect will be defined as the mean
score of the items ‘I feel insecure’, ‘I feel lonely’, ‘I feel
anxious’, ‘I feel irritated’, ‘I feel down’, ‘I feel desperate’, ‘I
feel tensed’, and ‘I feel confident’. A mean positive and
negative affect score will be calculated for each com-
pleted beep during the day, with higher scores indicating
higher levels of positive and negative affect.
Additional measures
Demographics: demographic variables, including age,
sex, and level of education of both the caregiver and the
care recipient, will be assessed during a demographical
interview with the caregiver. Furthermore, information
about the type, severity, and duration of dementia, care-
giver hours of contact with the PwD, caregiver hours of
caring for the PwD, and PwD hours spent in a dementia
day care setting will be collected. The Clinical Dementia
Rating scale (CDR) will be used to stage the severity of
the dementia [35]. The CDR score is rated on a 5-point
scale: 0 = ‘normal’; 0.5 = ‘very mild dementia’; 1 = ‘mild
dementia’; 2 = ‘moderate dementia’; and 3 = ‘severe de-
mentia’. The CDR has become widely accepted in the
clinical setting as a reliable and valid global assessment
measure of dementia [36].
Neuropsychiatric symptoms in the PwD: the Neuro-
psychiatric Inventory Questionnaire (NPI-Q), a brief
form of the Neuropsychiatric Inventory (NPI), will be
used to evaluate neuropsychiatric symptoms in the PwD
and associated caregiver distress [37]. The NPI-Q evalu-
ates twelve neuropsychiatric domains, including: delu-
sions, hallucinations, agitation/aggression, dysphoria/
depression, anxiety, euphoria, apathy, disinhibition, irrit-
ability, aberrant motor behavior, nighttime behavioral
disturbances, and appetite and eating abnormalities. For
each domain, the caregiver answers a screening question
to indicate whether the symptom is present or not. If
present, the severity is rated on a scale from 1 (mild) to 3
(severe). Total sum scores range from 0 to 36. Addition-
ally, a caregiver distress score is rated for each domain on
a 6-point scale, ranging from 0 (not emotionally
stressful) to 5 (extremely stressful). The Dutch version
of the NPI-Q has been investigated and appears to be
a valid instrument [38].
Quality of the relationship: quality of the relationship
will be assessed using four items of the University of
Southern California Longitudinal Study of Three-
Generation Families measures of positive affect [39]. The
items represent: general closeness, communication, simi-
larity of views on life, and degree of getting along with
each other. Answer scales range from 1 (not at all) to 4
(very). Caregivers will answer these items in terms of the
current situation and to what extent the relationship
changed since illness onset (1 =much better, 5 =much
worse). Summed scores will be used as an index of the
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change in relationship quality. A previous study found
good internal reliability [40].
Coping: the 44-item Utrechtse Coping List (UCL) will
be used to measure seven different coping strategies in
the caregiver, including seeking distraction (eight items),
expressing emotions (three items), seeking social support
(six items), avoiding (eight items), fostering reassuring
thoughts (five items), passive coping (seven items), and
active coping (seven items). Items are rated on a 4-point
scale, ranging from 1 (rarely or never use this strategy)
to 4 (very often use this strategy). The reliability and val-
idity has been found sufficient despite some inconsisten-
cies in the literature [41].
Personality: the 12-item Neuroticism domain of the NEO
Five-Factor Inventory (NEO-FFI) will be used to identify
subjects who are susceptible to psychological distress. This
domain measures six traits: anxiety, angry hostility, depres-
sion, self-consciousness, impulsiveness, and vulnerability.
Item scores will be rated on a 5-point scale, ranging from 0
(strongly disagree) to 4 (strongly agree), and will be accu-
mulated to generate a total sum score (range 0–48). The re-
liability and internal consistency of the Dutch version of the
NEO-FFI is good [42].
Outcome measures in the process evaluation
As part of the process evaluation, sampling quality and
intervention quality will be evaluated to determine the in-
ternal and external validity of the intervention program
and to reveal facilitators and barriers for the intervention.
Sampling quality: will be evaluated by describing (1)
the recruitment and randomization procedure; (2) the
informed consent and allocation procedure; and (3) bar-
riers and facilitators to the recruitment of caregivers.
Reach will be established by the proportion of caregivers
participating and the number of institutions involved in
the intervention.
Intervention quality: will be evaluated by determining
(1) the relevance of the intervention; (2) the feasibility of
the intervention; and (3) the extent to which the inter-
vention was performed according to protocol.
Required data will be collected from the research
database, and during the sessions with the coach and
the post-intervention assessment. Objective measures
of compliance with respect to the ESM procedure
(number of completed beeps) and the intervention
(number of drop-outs) will be examined. Technical
problems with the PsyMate will be logged. Subjective
experiences with respect to the intervention (i.e.
clearness, relevance, usability, impact on daily func-
tioning, satisfaction with procedure and time burden,
suggestions for improvement, and recommendations
to other caregivers) will be assessed by means of a
quantitative questionnaire and a qualitative interview
with the caregiver during the third feedback session.
In addition, subjective experiences with the PsyMate
and ESM procedure (e.g. difficulties operating the
device, clearness items, readability of the items on
the screen, interference with daily activities, and rea-
sons for missed beeps) will be examined.
Performance of the intervention according to protocol
will be evaluated with a structured registration form,
which includes protocol deviations and duration of each
face-to-face session during the intervention period.
Economic evaluation
The economic evaluation will involve a cost-effectiveness
analysis (CEA) and includes the assessment of costs as
well as outcomes of the intervention.
Resource use and costs: the Resource Utilization in
Dementia – shortened version (RUD-lite) will be used to
map the utilization of resources for both the PwD and
the caregiver [43]. The RUD-lite assesses both formal
and informal resource use, making it possible to calcu-
late costs from a societal point of view. Costs will be cal-
culated by multiplying the quantity of resource use by
the cost price per resource unit and will include the
period from the baseline assessment until the last
follow-up assessment (6 months). All relevant costs will
be determined according to the Dutch guidelines for
cost calculations in health care [44].
Intervention costs: intervention costs will include the
amount of time spent on briefing the caregivers regard-
ing the PsyMate and ESM procedure, the feedback ses-
sions with the coach, administration (e.g. writing short
feedback reports), telephone contact, the training session
for the coach on how to provide the feedback, and costs
of required materials (e.g. PsyMate). The coach will
register the duration of the feedback sessions, adminis-
tration, and telephone contact with the caregiver on a
structured registration form. Incremental cost effective-
ness ratios (ICER) will be calculated by dividing the dif-
ference in total costs between the treatment arms by the
difference in average effect size.
Quality of life: caregivers’ health related quality of life
will be measured with the EuroQol-5D (EQ-5D) and
consists of five items representing the following dimen-
sions mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression [45]. Respondents indicate their
health state by rating each dimension on a 3-level scale,
including 1 ‘no problems’, 2 ‘moderate problems’, or 3
‘severe problems’. In addition, the EQ-VAS will be used
to record caregivers’ self-rated health status on a Visual
Analogue Scale, anchored at ‘the best health you can im-
agine’ (100) and ‘the worst health you can imagine’ (0).
The EuroQol demonstrates a good test-retest reliability
[46]. For the cost-effectiveness analysis, quality-adjusted
life-years (QALYs) will be calculated according to the
Dutch EuroQol tariff [47].
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Sample size
The calculation of the sample size will be based on previ-
ous studies using the Sense of Competence Questionnaire
(SCQ) as outcome measure in intervention studies for
caregivers of PwD, the use of repeated measures, within-
between interaction with a mean effect size of 0.8 [48],
and the following assumptions: alpha 0.05, 80 % power
and 25 % loss to follow up. Accordingly, we aim to enrol
90 participants in the study (30 participants per group).
Statistical analyses
Primary and secondary outcome measures
Data will be entered twice to guarantee data integrity.
Before the analyses, data will be checked for missing
values and handled according to their distribution
(missing completely at random, missing at random, or
not missing at random), and the ‘intention-to-treat’
principle. Additionally, data will be checked for outliers,
and normality. Non-parametric tests will be used in case
of non-normality after data transformation. Possible
baseline differences in group characteristics will be
tested with t-tests for continuous and χ2-tests for
categorical variables.
To investigate changes in the primary and secondary
outcomes for each group during the intervention period,
an analysis of covariance (ANCOVA) will be performed
with outcome at post-intervention as the dependent
variable, group (experimental, pseudo-experimental,
control) as the between-subject factor, and outcome at
baseline and potential confounders (e.g. demographic
variables, coping, personality, and quality of the relation-
ship) as covariates. Separate analyses will be conducted
for each outcome variable. Group differences in the
post-intervention outcome, adjusted for the baseline
value, will be examined to test the effectiveness of the
intervention. In case group differences are present, the
inter-group effect size will be calculated using Cohen’s d.
To examine changes in the primary and secondary
outcomes for each group during the total study
period, a linear mixed model (LMM) for repeated
measures will be conducted. Analyses will be per-
formed with group as a fixed between-subject factor
(3 levels: experimental, pseudo-experimental, and con-
trol group) and time as fixed within-subject variable
(4 levels: baseline, post-intervention, two-month
follow-up, and six-month follow-up) and first-order
interactions as additional fixed factors. The LMM will
estimate fixed effects (regression slopes) for change in
the intervals during (T0-T1) and after (T1-T2, T2-T3)
the intervention period. The intervals will be entered
as a categorical dummy variable (3 levels). Potential
confounders will be added to the model as covariates.
Additionally, coach will be added as a random factor
to estimate the variability ascribed to the coach.
All data will be analysed using STATA 12.1 [49]. Tests
of significance will report mean change and will be two
tailed with α set at 0.05.
ESM outcome measures
Subjects have to complete at least 33 % of the ESM beeps in
order to be included in the ESM data analysis [4]. To inves-
tigate changes in momentary positive and negative affect be-
tween the 3-day ESM baseline and post measurement for
each group, an LMM will be performed for both outcome
measures. LMMs are ideally suited for ESM data, since these
models take into account the hierarchical data structure in
which multiple ESM observations (beep level 1) are nested
within days (day level 2), and days are nested within subjects
(subject level 3). The XTMIXED command in STATA 12.1
[49] will be used to conduct analyses with group (3 levels:
experimental, pseudo-experimental, and control group),
time (2 levels: baseline and post-intervention), and the two-
way interaction between group and time as fixed factors.
Random slopes, representing positive or negative affect, will
be added at the subject, day, and beep level. Potential con-
founders will be included in the model as covariates.
Process evaluation
Descriptive analyses will be conducted to summarize re-
sponse rates, overall experiences regarding the ESM
intervention and the PsyMate, and additional findings
with respect to the sampling and intervention quality.
Confidentiality
All study-related information will be stored securely
at the study site. All participant information will be
identified by a coded ID number to maintain partici-
pant confidentiality. The principal investigators and
project team members will be able to access the data.
All records that contain names or other personal
identifiers (e.g. informed consent forms) will be stored
separately from study records identified by code num-
ber. All datasets will be password protected.
Monitoring and participant safety
The study will be monitored externally by the trial monitor-
ing committee of the MUMC+ (Clinical Trial Center Maas-
tricht). The trial monitoring committee is independent of
the study organizers. All adverse events (AEs) and serious
adverse events (SAEs) that occur during the study will be re-
corded during the (feedback) sessions, the post-intervention
assessment, and the two- and six-month follow-up assess-
ment. SAEs will be reported to the accredited Medical Eth-
ical Committee that approved the protocol.
Withdrawal of participants
Participants can leave the study at any time without jus-
tification, and without any consequences.
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Discussion
The current paper presents the study protocol of an RCT
to evaluate the effectiveness of an ESM intervention to im-
prove caregivers’ sense of competence and control, and
psychological well-being. The potential effects of the inter-
vention may help caregivers to keep on caring and prevent
them from developing (more) health problems and becom-
ing overburdened. This study contains several unique as-
pects. To our knowledge, this is the first ESM intervention
for caregivers of PwD. ESM might be a promising tool in
both research and clinical practice, since it offers the possi-
bility to provide more detailed information on caregiver
functioning in the flow of daily life. In this study we will
use ESM as an intervention tool, but also as an assessment
tool to evaluate the effects of the intervention. Therefore,
an important advantage is that the results of this study rep-
resent a high level of ecological validity. Another unique
aspect is that our intervention focuses on positive rather
than negative experiences during the caretaking process.
Positive emotions are important facilitators of adaptive
coping and might increase caregivers’ feelings of being cap-
able to care [18, 50]. The ESM intervention might enhance
caregivers’ self-awareness and redirect their behavior to sit-
uations that are conducive to positive emotional experi-
ences. Moreover, the intervention includes ESM-derived
feedback that is tailored to the caregivers’ personal situ-
ation and actively involves them in their own empowering
process. Both are known to be important aspects of effect-
ive caregiver support interventions [14]. The inclusion of a
pseudo-experimental condition in our study design allows
us to unravel the added value of the ESM-derived feedback
to the use of the PsyMate in general. Caregivers might
benefit from the use of the PsyMate without receiving any
feedback, since repeated self-assessments may lead people
to pay more attention to their internal states and own be-
havior [21]. Lastly, the intervention program will be deliv-
ered in daily practice and offers the possibility to be
integrated in future clinical practice. The additional process
and economic evaluation will provide valuable information
on potential facilitators and barriers to implementation,
and on the cost-effectiveness of the intervention.
Certain limitations need to be acknowledged in advance.
There is a possibility of sample bias. Although participants
will be recruited in a wide range of different institutions,
the group that agrees to participate in the study might differ
from the group that refuses to participate. In general, par-
ticipants are expected to be relatively young, more highly
educated, and more pro-active in seeking for support [51].
Moreover, recent results from our feasibility study, in which
caregiver were asked to collect ESM data for only six con-
secutive days, showed that a large number of caregivers re-
fused to participate because of a too busy time schedule
(van Knippenberg et al.: Dealing with daily challenges in de-
mentia (Deal-id study): an innovative approach to assess
caregiver functioning in the flow of daily life, submitted).
The even more time-intensive nature of the current study
might, therefore, cause a selection bias towards caregivers
that are not yet facing extreme difficulties in the caregiving
process. It is also expected that a number of participants
will drop out of the ESM intervention prematurely. In this
specific population, it is likely that participants drop out for
specific disease related reasons, such as institutionalization
or death of the PwD. In a previous ESM study with persons
with depression, 15 % of the participants did not complete
the 6-week ESM intervention period [9]. The face-to-face
sessions with a coach and the delivery of personalized feed-
back, however, might increase caregivers’ motivation to par-
ticipate given that usual care for dementia caregivers often
does not, or very infrequent, include counseling [52].
In conclusion, the results of this study will provide a
valuable contribution to the growing knowledge on m-
health interventions for caregivers of PwD. Our ESM
intervention ‘Partner in Sight’ is expected to be effective
in terms of caregiver well-being and might be an innova-
tive approach to support caregivers of PwD in managing
daily challenges during the course of the disease.
Ethics approval and consent to participate
The Medical Ethical Committee of the MUMC+ ap-
proved this study (#143040). All participants gave in-
formed consent to participate in the study.
Protocol amendments
Important protocol modifications, which may impact on
the conduct of the study or may affect participant safety,
including changes in study objectives, study design, study
population, sample sizes, study procedures, or significant
administrative aspects will require a formal amendment to
protocol. Substantial amendments will be notified to the
principal investigators and approved by the Medical Eth-
ical Committee of the MUMC+ prior to implementation.
Minor changes to the protocol that have no effect on the
way the study is conducted will not be notified to the
Medical Ethical Committee of the MUMC+, but will be
recorded and filed by the investigators.
Consent for publication
Not applicable.
Availability of data
Not applicable.
Availability of supporting data
Not applicable.
SPIRIT Guidelines
This study protocol is based on the SPIRIT 2013 Statement
[53]. A SPIRIT checklist is provided as an additional file.
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Appendix
Table 3 Description of the ESM concepts, items and response choices in the daily, morning and evening questionnaire
Daily questionnaire
Concept Item Rating scale
Positive affect 1. I feel cheerful 7-point scale (1 ‘not at all’ to 7 ‘very much’)
2. I feel relaxed 7-point scale (1 ‘not at all’ to 7 ‘very much’)
3. I feel enthusiastic 7-point scale (1 ‘not at all’ to 7 ‘very much’)
4. I feel satisfied 7-point scale (1 ‘not at all’ to 7 ‘very much’)
Negative affect 5. I feel insecure 7-point scale (1 ‘not at all’ to 7 ‘very much’)
6. I feel lonely 7-point scale (1 ‘not at all’ to 7 ‘very much’)
7. I feel anxious 7-point scale (1 ‘not at all’ to 7 ‘very much’)
8. I feel irritated 7-point scale (1 ‘not at all’ to 7 ‘very much’)
9. I feel down 7-point scale (1 ‘not at all’ to 7 ‘very much’)
10. I feel desperate 7-point scale (1 ‘not at all’ to 7 ‘very much’)
11. I feel confident 7-point scale (1 ‘not at all’ to 7 ‘very much’)
12. I feel tensed -point scale (1 ‘not at all’ to 7 ‘very much’)
Self-esteem 13. I like myself 7-point scale (1 ‘not at all’ to 7 ‘very much’)
14. I am ashamed of myself 7-point scale (1 ‘not at all’ to 7 ‘very much’)
15. I doubt myself 7-point scale (1 ‘not at all’ to 7 ‘very much’)
16. I am satisfied with myself 7-point scale (1 ‘not at all’ to 7 ‘very much’)
Physical well-being 17. I am tired 7-point scale (1 ‘not at all’ to 7 ‘very much’)
18. I feel well 7-point scale (1 ‘not at all’ to 7 ‘very much’)
19. I am in pain 7-point scale (1 ‘not at all’ to 7 ‘very much’)
20. I have problems in walking 7-point scale (1 ‘not at all’ to 7 ‘very much’)
Activity 21. What am I doing? (just before the alert) Doing nothing; resting; work; household; self care; caring for
partner; active relaxation; passive relaxation; something else
22. And also? Doing nothing; resting; work; household; self care; caring for
partner; active relaxation; passive relaxation; something else
23. And…? Doing nothing; resting; work; household; self care; caring for
partner; active relaxation; passive relaxation; something else
24. I like doing this 7-point scale (1 ‘not at all’ to 7 ‘very much’)
25. I would rather be doing something else 7-point scale (1 ‘not at all’ to 7 ‘very much’)
26. This is difficult for me 7-point scale (1 ‘not at all’ to 7 ‘very much’)
27. I feel I am being active 7-point scale (1 ‘not at all’ to 7 ‘very much’)
28. I can do this well 7-point scale (1 ‘not at all’ to 7 ‘very much’)
29. I am doing this activity together with my partner Yes; no
Location 30. Where am I? At home; at family’s/friend’s place; at work; health care setting;
public place; transport; somewhere else
Social company 31. Who am I with? Partner; family; friends; colleagues; health care professional;
acquaintances; strangers/others; nobody
32. With whom else? Partner; family; friends; colleagues; health care professional;
acquaintances; strangers/others; nobody
33. And…? Partner; family; friends; colleagues; health care professional;
acquaintances; strangers/others; nobody
Branching questions in case of being in company:
34. I would prefer to be alone 7-point scale (1 ‘not at all’ to 7 ‘very much’)
35. I think my company is pleasant 7-point scale (1 ‘not at all’ to 7 ‘very much’)
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Table 3 Description of the ESM concepts, items and response choices in the daily, morning and evening questionnaire (Continued)
36. I feel at ease in this company 7-point scale (1 ‘not at all’ to 7 ‘very much’)
Branching questions in case of being alone:
34. I would prefer to be in company of others 7-point scale (1 ‘not at all’ to 7 ‘very much’)
35. I enjoy being alone 7-point scale (1 ‘not at all’ to 7 ‘very much’)
36. I feel at ease being alone 7-point scale (1 ‘not at all’ to 7 ‘very much’)
Events 37. Since the last alert the most important thing that
happened is…
(take an event in mind before you continue)
38. How pleasant was this event? bipolar scale (−3 ‘very unpleasant’ to +3 ‘very pleasant’)
39. I had this situation under control 7-point scale (1 ‘not at all’ to 7 ‘very much’)
40. Was this situation unexpected? 7-point scale (1 ‘not at all’ to 7 ‘very much’)
41. The event was important to me bipolar scale (−3 ‘very unimportant’ to +3 ‘very important’)
42. With whom was I? Partner; nobody; someone else
General 43. This alert disturbed me 7-point scale (1 ‘not at all’ to 7 ‘very much’)
Morning
questionnaire
1. I slept well 7-point scale (1 ‘not at all’ to 7 ‘very much’)
2. How long did it take before I fell asleep 0–5 min; 5–15 min; 30–45 min; 45–60 min; 1-2 h; 2 4 h; >4 h
3. How often did I wake up last night 1 time; 2 times; 3 times; 4 times; 5 times; more than 5 times
4. My partner disturbed my sleep 7-point scale (1 ‘not at all’ to 7 ‘very much’)
5. I feel rested 7-point scale (1 ‘not at all’ to 7 ‘very much’)
6. I feel apprehensive about today 7-point scale (1 ‘not at all’ to 7 ‘very much’)
Evening
questionnaire
1. This was an ordinary day 7-point scale (1 ‘not at all’ to 7 ‘very much’)
2. If I had not had the device, I would have done
different things today
7-point scale (1 ‘not at all’ to 7 ‘very much’)
3. I generally felt well today 7-point scale (1 ‘not at all’ to 7 ‘very much’)
4. I generally felt tired today 7-point scale (1 ‘not at all’ to 7 ‘very much’)
5. I generally felt tensed today 7-point scale (1 ‘not at all’ to 7 ‘very much’)
6. I generally worried a lot today 7-point scale (1 ‘not at all’ to 7 ‘very much’)
7. I generally felt able to manage today 7-point scale (1 ‘not at all’ to 7 ‘very much’)
8. My health state was good today Visual Analogue Scale (0 ‘worst imaginable health’ to 100
‘best imaginable health’)
9. How many hours did you spend on caring for your
partner today (incl. supervision)
0 h; 1 h; 2 h; 3 h; 4 h; 5 h; >5 h
10. Today I felt strained in the interactions with my partner 7-point scale (1 ‘not at all’ to 7 ‘very much’)
11. Today I felt stressed due to my care responsibilities 7-point scale (1 ‘not at all’ to 7 ‘very much’)
12. Today I felt that the situation with my partner did not
allow me as much privacy as I would have liked
7-point scale (1 ‘not at all’ to 7 ‘very much’)
13. Today I had enough time for myself 7-point scale (1 ‘not at all’ to 7 ‘very much’)
14. Today I was in need of support 7-point scale (1 ‘not at all’ to 7 ‘very much’)
15. Today I received enough support 7-point scale (1 ‘not at all’ to 7 ‘very much’)
Today, to what extent did your partner suffer from:
16. Being sad or depressed 7-point scale (1 ‘not at all’ to 7 ‘very much’)
17. Being anxious our nervous 7-point scale (1 ‘not at all’ to 7 ‘very much’)
18. Acting impulsively or embarrassing 7-point scale (1 ‘not at all’ to 7 ‘very much’)
19. A loss of interest in activities/other people 7-point scale (1 ‘not at all’ to 7 ‘very much’)
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